Skip to main content
Top
Published in: Japanese Journal of Radiology 10/2017

01-10-2017 | Original Article

Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents

Authors: Khongorzul Erdene, Takahito Nakajima, Satomi Kameo, Miski Aghnia Khairinisa, Oyunbold Lamid-Ochir, Amartuvshin Tumenjargal, Noriyuki Koibuchi, Hiroshi Koyama, Yoshito Tsushima

Published in: Japanese Journal of Radiology | Issue 10/2017

Login to get access

Abstract

Purpose

To investigate the effect of pregnancy and type of gadolinium (Gd)-based contrast agents (GBCAs) on organ retention of Gd in mother and pup mice after maternal administration.

Materials and methods

Gd-DTPA-BMA (gadodiamide) or Gd-DOTA (gadoterate dimeglumine) was administered (2.0 mmol/kg of maternal weight) four times to pregnant Balb/c mice from gestational day 16–19, respectively. At 28 days after birth, they were euthanized and their organs (blood, brain, liver, kidney, spleen, and bone) were removed for the measurement of Gd by inductively coupled plasma mass spectrometry.

Results

Gd retention in maternal organs was generally lower than that in the organs of non-pregnant mice in both Gd-DTPA-BMA and Gd-DOTA groups. Significantly higher Gd retention was observed in the organs of pups whose mothers were administered Gd-DTPA-BMA as compared to those whose mothers were administered Gd-DOTA. Tissue-to-muscle ratio in the brains of pups was higher than that of mothers.

Conclusion

We demonstrated in utero transplacental Gd retention in pups. In various organs in both mothers and pups, Gd retention was consistently higher for Gd-DTPA-BMA than Gd-DOTA administration. Pregnancy affected Gd retention in many maternal organs.
Literature
1.
go back to reference Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging. 2006;1(3):128–37.CrossRefPubMed Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging. 2006;1(3):128–37.CrossRefPubMed
2.
go back to reference Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C. Invest Radiol. 2008;43(12):817–28.CrossRefPubMed Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C. Invest Radiol. 2008;43(12):817–28.CrossRefPubMed
3.
4.
go back to reference Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol. 2008;158(2):273–80.CrossRefPubMed Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol. 2008;158(2):273–80.CrossRefPubMed
5.
go back to reference Tsushima Y, Kanal E, Thomsen HS. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. Br J Radiol. 2010;83(991):590–5.CrossRefPubMedPubMedCentral Tsushima Y, Kanal E, Thomsen HS. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. Br J Radiol. 2010;83(991):590–5.CrossRefPubMedPubMedCentral
6.
go back to reference High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2007;56(1):21–6.CrossRefPubMed High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2007;56(1):21–6.CrossRefPubMed
7.
go back to reference Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69(7):661–8.CrossRefPubMed Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69(7):661–8.CrossRefPubMed
8.
go back to reference Roberts DR, Lindhorst SM, Welsh CT, Maravilla KR, Herring MN, Braun KA, et al. High levels of gadolinium deposition in the skin of a patient with normal renal function. Invest Radiol. 2016;51(5):280–9.PubMed Roberts DR, Lindhorst SM, Welsh CT, Maravilla KR, Herring MN, Braun KA, et al. High levels of gadolinium deposition in the skin of a patient with normal renal function. Invest Radiol. 2016;51(5):280–9.PubMed
9.
go back to reference Guidelines for diagnostic imaging during pregnancy and lactation. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Obstet Gynecol. 2016;127(2):e75–80.CrossRef Guidelines for diagnostic imaging during pregnancy and lactation. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Obstet Gynecol. 2016;127(2):e75–80.CrossRef
10.
go back to reference Patenaude Y, Pugash D, Lim K, Morin L, Diagnostic Imaging C, Lim K, et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36(4):349–63.CrossRefPubMed Patenaude Y, Pugash D, Lim K, Morin L, Diagnostic Imaging C, Lim K, et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36(4):349–63.CrossRefPubMed
11.
12.
go back to reference Birchard KR, Brown MA, Hyslop WB, Firat Z, Semelka RC. MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol. 2005;184(2):452–8.CrossRefPubMed Birchard KR, Brown MA, Hyslop WB, Firat Z, Semelka RC. MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol. 2005;184(2):452–8.CrossRefPubMed
13.
go back to reference Khurana A, Nickel AE, Greene JF Jr, Narayanan M, High WA, Foulks CJ. Successful pregnancy in a hemodialysis patient and marked resolution of her nephrogenic systemic fibrosis. Am J Kidney Dis. 2008;51(6):e29–32.CrossRefPubMed Khurana A, Nickel AE, Greene JF Jr, Narayanan M, High WA, Foulks CJ. Successful pregnancy in a hemodialysis patient and marked resolution of her nephrogenic systemic fibrosis. Am J Kidney Dis. 2008;51(6):e29–32.CrossRefPubMed
14.
go back to reference Muhler MR, Clement O, Salomon LJ, Balvay D, Autret G, Vayssettes C, et al. Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. Radiology. 2011;258(2):455–60.CrossRefPubMed Muhler MR, Clement O, Salomon LJ, Balvay D, Autret G, Vayssettes C, et al. Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. Radiology. 2011;258(2):455–60.CrossRefPubMed
15.
go back to reference Oh KY, Roberts VH, Schabel MC, Grove KL, Woods M, Frias AE. Gadolinium chelate contrast material in pregnancy: fetal biodistribution in the nonhuman primate. Radiology. 2015;276(1):110–8.CrossRefPubMedPubMedCentral Oh KY, Roberts VH, Schabel MC, Grove KL, Woods M, Frias AE. Gadolinium chelate contrast material in pregnancy: fetal biodistribution in the nonhuman primate. Radiology. 2015;276(1):110–8.CrossRefPubMedPubMedCentral
17.
go back to reference Kartamihardja AA, Nakajima T, Kameo S, Koyama H, Tsushima Y. Impact of impaired renal function on gadolinium retention after administration of gadolinium-based contrast agents in a mouse model. Invest Radiol. 2016;51(10):655–60.CrossRefPubMed Kartamihardja AA, Nakajima T, Kameo S, Koyama H, Tsushima Y. Impact of impaired renal function on gadolinium retention after administration of gadolinium-based contrast agents in a mouse model. Invest Radiol. 2016;51(10):655–60.CrossRefPubMed
18.
19.
go back to reference Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270(3):834–41.CrossRefPubMed Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270(3):834–41.CrossRefPubMed
20.
go back to reference Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology. 2015;276(1):228–32.CrossRefPubMed Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology. 2015;276(1):228–32.CrossRefPubMed
21.
go back to reference Robert P, Violas X, Grand S, Lehericy S, Idee JM, Ballet S, et al. Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats. Invest Radiol. 2016;51(2):73–82.CrossRefPubMedPubMedCentral Robert P, Violas X, Grand S, Lehericy S, Idee JM, Ballet S, et al. Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats. Invest Radiol. 2016;51(2):73–82.CrossRefPubMedPubMedCentral
Metadata
Title
Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents
Authors
Khongorzul Erdene
Takahito Nakajima
Satomi Kameo
Miski Aghnia Khairinisa
Oyunbold Lamid-Ochir
Amartuvshin Tumenjargal
Noriyuki Koibuchi
Hiroshi Koyama
Yoshito Tsushima
Publication date
01-10-2017
Publisher
Springer Japan
Published in
Japanese Journal of Radiology / Issue 10/2017
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-017-0667-2

Other articles of this Issue 10/2017

Japanese Journal of Radiology 10/2017 Go to the issue